Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
EJNMMI Research|December 6, 2019
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapyShiro Watanabe, Tetsuya Inoue, Shozo Okamoto, et al.
Respiratory Investigation|June 13, 2026
Clinical characteristics of long-term survivors of small cell lung cancerYuki Hatakeyama, Daisuke Morinaga, Jun Sakakibara-Konishi, et al.
Internal Medicine (Tokyo, Japan)|February 14, 2018
Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor ShrinkageTetsuaki Shoji, Hidenori Mizugaki, Yasuyuki Ikezawa, et al.
International Journal of Clinical Oncology|May 17, 2024
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET studyKaname Nosaki, Kiyotaka Yoh, Ryo Toyozawa, et al.
Cancer Science|December 18, 2022
EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironmentAkihiko Shiiya, Takuro Noguchi, Utano Tomaru, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.
Cancer Treatment and Research Communications|January 20, 2026
Phase 1/2 trial of brigatinib plus panitumumab in patients with osimertinib-resistant EGFR-mutated non-small cell lung cancer harboring EGFR C797S mutationHiroki Izumi, Tomohiro Sakamoto, Ken Uchibori, et al.
Journal of Radiation Research|May 14, 2026
Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective studyTomohiko Miyazaki, Koichi Yasuda, Hiroshi Taguchi, et al.
Cancer Medicine|July 5, 2025
Utility of a Novel High-Sensitivity Multiplex Companion Diagnostic Test Using Formalin-Fixed Paraffin-Embedded Cell Block Materials of Non-small Cell Lung CancerYoshiki Shinomiya, Yuko Ishida, Kanako C Hatanaka, et al.
Japanese Journal of Clinical Oncology|July 26, 2026
Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort studyShinsuke Yamashita, Yoshitaka Saito, Shinya Tamaki, et al.
Pageof 10